NDC 25682-010
STRENSIQ
Asfotase Alfa
STRENSIQ is a Subcutaneous Solution in the Human Prescription Drug category. It is labeled and distributed by Alexion Pharmaceuticals, Inc.. The primary component is Asfotase Alfa.
Product ID | 25682-010_09d53de9-6c11-4f9f-9807-9141f9b7a91d |
NDC | 25682-010 |
Product Type | Human Prescription Drug |
Proprietary Name | STRENSIQ |
Generic Name | Asfotase Alfa |
Dosage Form | Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2015-10-23 |
Marketing Category | BLA / BLA |
Application Number | BLA125513 |
Labeler Name | Alexion Pharmaceuticals, Inc. |
Substance Name | ASFOTASE ALFA |
Active Ingredient Strength | 18 mg/.45mL |
Pharm Classes | Alkaline Phosphatase [CS], Tissue-nonspecific Alkaline Phosphatase [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |